99% Savings - Buy Just @1 Rs X
Nebicard LN 2.5 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebicard LN 2.5 Tablet (10) safe for pregnant women?
Nebicard LN Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Nebicard LN 2.5 Tablet (10) safe during breastfeeding?
Nebicard LN Tablet should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Kidneys?
Nebicard LN Tablet rarely harms the kidneys.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Liver?
Very few cases of side effects of Nebicard LN Tablet on the liver have been reported.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Heart?
Very few cases of side effects of Nebicard LN Tablet on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Nebicard LN 2.5 Tablet (10) unless your doctor advises you to do so -
Is this Nebicard LN 2.5 Tablet (10) habit forming or addictive?
Forming a habit of Nebicard LN 2.5 Tablet (10) has not been reported.
Interaction between Food and Nebicard LN 2.5 Tablet (10)
Nebicard LN 2.5 Tablet (10) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Nebicard LN 2.5 Tablet (10)
Consuming Nebicard LN 2.5 Tablet (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897